electroCore, Inc.
ECOR4.600USD
+0.180+4.07%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
35.12MMarket Cap
LossP/E TTM
More Details of electroCore, Inc. Company
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.
electroCore, Inc. Info
Ticker SymbolECOR
Company nameelectroCore, Inc.
IPO dateJun 22, 2018
CEOGoldberger (Daniel S)
Number of employees73
Security typeOrdinary Share
Fiscal year-endJun 22
Address200 Forge Way
CityROCKAWAY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07866
Phone19732900097
Websitehttps://www.electrocore.com/
Ticker SymbolECOR
IPO dateJun 22, 2018
CEOGoldberger (Daniel S)
Company Executives of electroCore, Inc.
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
185.90K
+0.54%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+22.69%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+27.52%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+35.66%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
--
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
185.90K
+0.54%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+22.69%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+27.52%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+35.66%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
--
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Rx gammaCore - Department of Veteran Affairs and Department of Defense
5.18M
70.25%
Truvaga
994.00K
13.47%
Outside the United States
465.00K
6.30%
Rx gammaCore - U.S. Commercial
394.00K
5.34%
TAC-STIM
181.00K
2.45%
Other
162.00K
2.19%
By RegionUSD
Name
Revenue
Proportion
United States
6.89M
93.42%
United Kingdom
433.00K
5.87%
Other
36.00K
0.49%
Japan
17.00K
0.23%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Rx gammaCore - Department of Veteran Affairs and Department of Defense
5.18M
70.25%
Truvaga
994.00K
13.47%
Outside the United States
465.00K
6.30%
Rx gammaCore - U.S. Commercial
394.00K
5.34%
TAC-STIM
181.00K
2.45%
Other
162.00K
2.19%
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
2.92%
Other
73.10%
Shareholders
Shareholders
Proportion
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
2.92%
Other
73.10%
Shareholder Types
Shareholders
Proportion
Individual Investor
26.93%
Corporation
8.76%
Investment Advisor
6.05%
Hedge Fund
1.57%
Investment Advisor/Hedge Fund
1.36%
Research Firm
0.02%
Other
55.31%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
75
727.72K
16.70%
--
2025Q3
75
727.72K
17.61%
-444.98K
2025Q2
70
1.17M
19.50%
-199.13K
2025Q1
65
1.37M
13.77%
+380.78K
2024Q4
69
936.59K
18.00%
-138.83K
2024Q3
59
1.06M
17.69%
+20.62K
2024Q2
62
1.04M
19.14%
+51.56K
2024Q1
68
992.08K
19.07%
-152.78K
2023Q4
66
961.96K
18.72%
+22.04K
2023Q3
73
937.71K
13.66%
+316.94K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Zhang (Tianyi)
734.64K
9.25%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.6%
--
--
Jul 04, 2025
Hilve Holdings Ltd
432.00K
5.44%
+432.00K
--
Aug 15, 2025
Errico (Thomas J.)
306.38K
3.86%
+26.61K
+9.51%
Sep 02, 2025
The Vanguard Group, Inc.
232.33K
2.92%
--
--
Jun 30, 2025
Goldberger (Daniel S)
184.90K
2.33%
+1.00K
+0.54%
Aug 11, 2025
Happy Holstein Management, LLC
153.17K
1.93%
--
--
Jul 04, 2025
MAZ Partners, L.P.
115.52K
1.45%
-156.44K
-57.52%
May 13, 2025
Patton (Thomas M)
102.78K
1.29%
+19.01K
+22.69%
Sep 02, 2025
Goldstein (Julie Ann)
101.39K
1.28%
+19.01K
+23.08%
Sep 02, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Date
Type
Ratio
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
FAQs
Who are the top five shareholders of electroCore, Inc.?
The top five shareholders of electroCore, Inc. are:
Zhang (Tianyi) holds 734.64K shares, accounting for 9.25% of the total shares.
Theofilos (Charles Steve) holds 444.53K shares, accounting for 5.60% of the total shares.
Hilve Holdings Ltd holds 432.00K shares, accounting for 5.44% of the total shares.
Errico (Thomas J.) holds 306.38K shares, accounting for 3.86% of the total shares.
The Vanguard Group, Inc. holds 232.33K shares, accounting for 2.92% of the total shares.
Zhang (Tianyi) holds 734.64K shares, accounting for 9.25% of the total shares.
Theofilos (Charles Steve) holds 444.53K shares, accounting for 5.60% of the total shares.
Hilve Holdings Ltd holds 432.00K shares, accounting for 5.44% of the total shares.
Errico (Thomas J.) holds 306.38K shares, accounting for 3.86% of the total shares.
The Vanguard Group, Inc. holds 232.33K shares, accounting for 2.92% of the total shares.
What are the top three shareholder types of electroCore, Inc.?
The top three shareholder types of electroCore, Inc. are:
Zhang (Tianyi)
Theofilos (Charles Steve)
Hilve Holdings Ltd
Zhang (Tianyi)
Theofilos (Charles Steve)
Hilve Holdings Ltd
How many institutions hold shares of electroCore, Inc. (ECOR)?
As of 2025Q4, 75 institutions hold shares of electroCore, Inc., with a combined market value of approximately 727.72K, accounting for 16.70% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.91%.
What is the biggest source of revenue for electroCore, Inc.?
In FY2025Q2, the Rx gammaCore - Department of Veteran Affairs and Department of Defense business generated the highest revenue for electroCore, Inc., amounting to 5.18M and accounting for 70.25% of total revenue.
